follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

DiaVacs Inc. appoints chief medical officer

By

Back to Top Comments Email Print

News You Can Use

Latest News

advertisement

Edgewater-based biotechnology company DiaVacs Inc. announced today the appointment of Dr. Orville Kolterman as chief medical officer. Kolterman will assume responsibility for the company's clinical development and medical affairs.

According to the announcement, the proprietary core technologies DiaVacs employs to create its dendritic cell therapies allow the immune system to be "retrained" to halt autoimmune attacks against the body's own tissues.

Share This Story On:

Write to the Editorial Department at editorial@njbiz.com

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top